The state of District Of Columbia currently has 1 active clinical trials seeking participants for Crohn's Disease research studies. These trials are conducted in various cities, including Washington, Washington, D.C., Washington DC and Washington, Dc.
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
06/18/2024
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia
Conditions: Crohn's Disease